Targeted Nrf2 activation therapy with RTA 408 enhances regenerative capacity of diabetic wounds

Authors:

Abstract
No abstract available
Funding Information
  • National Center for Advancing Translational Sciences (UL1 TR00038)
  • National Institutes of Health
  • Laura and Isaac Perlmutter Cancer Center (NIH/NCI P30CA016087)
  • National Institutes of Health S10 (NIH/ORIP S10OD01058, S10OD018338)
  • Reata Pharmaceuticals

This publication has 25 references indexed in Scilit: